Find P38 MAPK Inhibitors, SB203580 Inhibitor, Skepinone-L Inhibitor on Industry Directory, Reliable Manufacturer/Supplier/Factory from China.

Inquiry Basket (0)
Home > Products > MAPK > p38 MAPK Inhibitor > Losmapimod (GW856553X) 585543-15-3

Losmapimod (GW856553X) 585543-15-3

Product Description

.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}


Molecular Weight:

383.46 Losmapimod (GW856553X) is a selective, potent, and orally active p38 MAPK Inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively. Phase 3.


Biological Activity

Description Losmapimod (GW856553X) is a selective, potent, and orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively. Phase 3.
Targets p38α [1] p38β [1]
IC50 8.1(pKi) 7.6(pKi)
In vitro
In vivo In spontaneously hypertensive stroke-prone rats (SHR-SP), Losmapimod significantly improves survival, endothelial-dependent and -independent vascular relaxation, and indices of renal function, and subsequently attenuates dyslipidemia, hypertension, cardiac remodeling, plasma renin activity (PRA), aldosterone, and interleukin-1beta (IL-1beta).
Features


Protocol(Only for Reference)


Kinase Assay: [1]

In vitro assay Inhibition of p38α and p38β are determined by use of a ligand-displacement fluorescence polarization assay.


Animal Study: [1]

Animal Models Spontaneously hypertensive stroke-prone rats
Formulation
Dosages ~12 mg/kg
Administration p.o.


Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)


Species Baboon Dog Monkey Rabbit Guinea pig Rat Hamster Mouse
Weight (kg) 12 10 3 1.8 0.4 0.15 0.08 0.02
Body Surface Area (m2) 0.6 0.5 0.24 0.15 0.05 0.025 0.02 0.007
Km factor 20 20 12 12 8 6 5 3

Animal A (mg/kg) = Animal B (mg/kg) multiplied by Animal B Km
Animal A Km



For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) × mouse Km(3) = 11.2 mg/kg
rat Km(6)









Chemical Information




Molecular Weight (MW) 383.46
Formula

C22 H26 F N3 O2

CAS No. 585543-15-3

Storage 3 years -20℃Powder
6 months-80℃in solvent (DMSO, water, etc.)
Synonyms GW856553, GSK-AHAB



Solubility (25°C) * In vitro DMSO 76 mg/mL (198.19 mM)
Water <1 mg/mL (
Ethanol 41 mg/mL heating (106.92 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.




Chemical Name 3-Pyridinecarboxamide, 6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-







Molarity Calculator
Dilution Calculator
Molecular Weight Calculator

Contact us if you need more details on 585543-15-3. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Losmapimod 585543-15-3、GW856553X 585543-15-3. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : MAPK > p38 MAPK Inhibitor